IL6 and Hyperglycemia: Hyperglycemia-induced polymorphonuclear (PMN) dysfunction has been related (in patients with and without DM) to a significantly reduced chemotaxis and with increased complications in these patients due to increased secretion of IL-1, IL-6 and TNF-α (51).